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RNA localization contributes to cell polarity and syn-
aptic plasticity. Evidence will be discussed that RNA
transport and local translation in neurons may be
more intimately linked than originally thought. Sec-
ond, neuronal RNA granules, originally defined as in-
termediates involved in mRNA transport, are much
more diverse in their composition and functions than
previously anticipated. We focus on three classes of
RNA granules that include transport RNPs, stress
granules, and P bodies and discuss their potential
functions in RNA localization, microRNA-mediated
translational regulation, and mRNA degradation.
Translational control of localized mRNAs is a common
mechanism for regulating protein expression in specific
subdomains of a cell. It plays an important role in a num-
ber of processes, such as the formation of the body
axes, asymmetric cell division, and cell motility (St
Johnston, 2005). In neurons, localization of mRNAs at
the synapse has been proposed as a mechanism for
synaptic plasticity and thus learning and memory (Klann
and Dever, 2004). Recently, it has also been shown that
mRNA targeting and local protein synthesis can influ-
ence axon guidance and nerve regeneration (Willis
et al., 2005). It is now generally accepted that localized
mRNAs are often transported in large ribonucleoprotein
particles (RNPs), which have been referred to as RNA
granules (Ainger et al., 1993; Knowles et al., 1996; Ko¨hr-
mann et al., 1999; Kiebler and DesGroseillers, 2000).
Interestingly, there may be alternative models for RNA
localization. In the Drosophila egg, hsp83 mRNA can
be localized by degrading all transcripts that are not cor-
rectly localized, and transcripts can also become local-
ized by passively diffusing through the cytoplasm until
they are locally anchored (St. Johnston, 2005, and refer-
ences therein). In yeast, ER tubules are involved in the
localization of ASH1 mRNA to the bud, suggesting a
myosin-dependent cotransport of tubules and localized
RNPs (Schmid et al., 2006). In this review, we focus on
progress to define RNPs involved in mRNA localization,
sorting, and degradation.
Significant progress has been made in identifying
components of such localized RNPs. A thorough com-
parison revealed that some RNP components are con-
served across species and used in different cellular con-
texts (Kiebler and DesGroseillers, 2000, and references
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tial for RNA localization in polarized neurons. This leaves
us with several important questions. First, are there dif-
ferent types of RNA granules for different RNAs, or do all
RNPs contain an obligatory subset of trans-acting fac-
tors? Second, how are RNAs translationally repressed
until they reach their final destinations? Do these neuro-
nal RNA granules, for example, contain microRNAs that
silence the transported messages? Third, how do trans-
port RNPs relate to stress granules and processing bod-
ies, two recently discovered RNA granules in mamma-
lian cells? Are these different RNA granules invariantly
particles with specific functions and independent as-
sembly pathways, or are these dynamic structures that
share components or even interconvert? We will focus
on neuronal RNA granules and review the evidence for
their role in neuronal RNA transport, translational regula-
tion, and possibly in RNA processing.
The Discovery of Transport RNPs
Many in situ hybridization studies (ISH) studies had pre-
viously revealed the nonrandom localization of specific
mRNAs to subcellular domains of polarized cells, such
as yeast, oocytes, fibroblasts, and neurons (St. John-
ston, 2005). However, these studies only provided infor-
mation on the steady-state distribution of mRNAs, and
alternative approaches were needed in live cells to un-
derstand the dynamic process of mRNA localization. In
a seminal study, Ainger et al. (1993) fluorescently labeled
and microinjected myelin basic protein (MBP) mRNA
into cultured oligodendrocytes. The MBP mRNA formed
granules, which were rapidly transported along microtu-
bules (MT) into processes at a rate of 0.2 mm/s. The ob-
served RNA granules were heterogeneous in size and
displayed persistent, oscillatory, or immobile character-
istics. This work represented the first characterization of
mRNA movements in living cells and suggested RNA
granules as intermediates in a multistep pathway to lo-
calize mRNAs (Ainger et al., 1993). Wilhelm and Vale
were the first to call them ‘‘RNA transport particles’’
(Wilhelm and Vale, 1993); we therefore refer to them as
transport RNPs.
In neurons, the first evidence for the existence of
transport RNPs (Table 1) came from Knowles et al.
(1996). The fluorescent vital RNA dye SYTO14 depicted
the dynamic movements of endogenous RNA granules
into dendrites of cultured cortical neurons. These trans-
port RNPs displayed rapid anterograde and retrograde
trajectories that were dependent on MTs, consistent
with an active transport process (Knowles et al., 1996).
Furthermore, they contained many translational compo-
nents, such as elongation factors and ribosomal pro-
teins or even clusters of ribosomes, supporting the pre-
vious findings on MBP mRNA granules. These findings
led to the hypothesis that transport RNPs move as dis-
crete units together with at least some of the machinery
needed to initiate translation upon reaching their final
destination.
This leads us to an important question: are RNA gran-
ules homogeneous in composition and function, or do
various types exist? Evidence for the latter hypothesis
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686Table 1. Diversity of Cytoplasmic RNA Granules in Neurons
Name Synonyms Definitions Key Components Key References
Transport RNPs Neuronal RNA
granules,
RNA particles
Motile granules transporting mRNA. Staufen1, Staufen2,
FMRP, ZBP1,
hnRNPA2, CPEB,
Pura, SMN
Knowles et al., 1996;
Ko¨hrmann et al., 1999;
Zhang et al., 2001, 2006;
Tang et al., 2001;
Huang et al., 2003;
Kanai et al., 2004
Contain translational components.
mRNAs in these RNA granules are
translationally arrested during
transport by the action of
regulatory RNAs and RNA-binding
proteins.
Biochemical evidence for RNA
granules with and
without ribosomes.
Stress granules Heat stress granules Harbor translationally arrested
mRNAs that form in cells
exposed to a broad range
of stresses.
TIA-1, TIAR, PABP,
G3BP, 40S
ribosomal subunit
Anderson and Kedersha, 2006;
Vessey et al., 2006
Sort, remodel, and export specific
RNAs for reinitiation or storage.
Processing bodies
(P bodies)
Cytoplasmic bodies,
Dcp1 bodies,
GW bodies
Sites of translational repression
and/or mRNA degradation.
Dcp1a, Lsm proteins,
Rck/p54, GW182
Anderson and Kedersha, 2006;
Schratt et al., 2006;
Vessey et al., 2006Contain RISC machinery
including microRNAs.
Do not contain ribosomal subunits.
Since the first description of motile transport RNPs in oligodendrocytes and neurons, at least two additional classes of neuronal RNA granules
exist: stress granules and P bodies that are sites for RNA storage and degradation, respectively. With regard to possible shared components
between these neuronal RNA granules, there is evidence that several mRNA binding proteins, i.e. staufen1, staufen2, FMRP, SMN, CPEB,
and pumilio2, can associate with SGs upon overexpression (Anderson and Kedersha, 2006). The presence of components in more than one
type of RNA granule suggests that these RNPs are not homogeneous, but represent dynamic structures that a cell uses to sort mRNAs and reg-
ulate their translation and degradation.came from several laboratories that have identified
mRNA binding proteins involved in mRNA localization
in polarized cells. One key player is Staufen, a double-
stranded RNA binding protein that plays important roles
in localization of bicoid and oskar RNA to the anterior
and posterior pole, respectively, in Drosophila oocytes
(St Johnston, 2005). Ko¨hrmann and colleagues were
the first to express the mammalian Staufen homolog
tagged with GFP in hippocampal neurons and to ob-
serve the MT-dependent recruitment of Staufen into
RNA granules, which exhibited rapid bidirectional move-
ments in dendrites (0.1–0.4 mm/s). This was the first
demonstration of dynamic movement of an RNA binding
protein in transport RNPs in living neurons (Ko¨hrmann
et al., 1999). This approach was subsequently used by
Zhang and colleagues to analyze the movement of gran-
ules (over 1 mm/s) containing the b-actin mRNA binding
protein zipcode binding protein 1 (ZBP1) into growth
cones of developing axons (Zhang et al., 2001). Further-
more, anterograde trafficking of RNA granules contain-
ing ZBP1 and b-actin mRNA was stimulated by the
neurotrophin NT-3, suggesting that granules can be reg-
ulated by physiological signals. Rook and colleagues
took a different approach to visualize RNPs in neurons
by employing the MS2-GFP tagging system to show
that movement of granules containing the 30-UTR for
CaMKIIa mRNA in dendrites is dependent on synaptic
activity (Rook et al., 2000). Neuronal depolarization in-
creased the fraction of the CaMKIIa reporter mRNA
that was in the anterograde motile pool, suggesting
that oscillatory granules were capable of sampling mul-
tiple nearby synapses. These finding indicate a possible
role of synaptic input in the regulation of RNA granule
motility in dendrites and localization at synapses. Taken
together, these studies underscore that not only aremRNAs packaged into transport RNPs for directed
movement but that there are signaling mechanisms
likely regulating distinct populations of these transport
RNPs and their dynamic interrelationships.
Live cell imaging studies are consistent with the no-
tion that transport RNPs may be propelled by molecular
motors. First, MT-depolymerizing drugs were shown to
decrease the levels of RNAs or mRNA binding proteins
in neuronal processes (Knowles et al., 1996; Ko¨hrmann
et al., 1999; Rook et al., 2000). Second, the observed ve-
locities of RNA granules (0.2–1.5 mm/s) and their antero-
grade or retrograde trajectories over long distances fur-
ther suggest that they depend on kinesin and dynein
motors. Indeed, previous work from the Carson group
showed that antisense knockdown of the conventional
kinesin heavy chain (KIF5b) impaired the ability of micro-
injectedMBPmRNA to translocate into oligodendrocyte
processes. Kanai and colleagues found that KIF5b asso-
ciates with large RNA granules that contain 42 proteins
and two well-studied dendritically localized mRNAs,
CaMKIIa and Arc (Kanai et al., 2004). Overexpression
of KIF5b increased mRNA localization into distal den-
drites, whereas mRNA localization was reduced follow-
ing its knockdown. Further work is needed to define the
specific molecular interactions between transport RNP
components and kinesin subunits to enable directed
RNA movement. Nonetheless, this study provides com-
pelling evidence that the anterograde transport of at
least some transport RNPs is mediated by conventional
kinesin in hippocampal neurons. It will also be important
to study how transport RNPs that are capable of bidirec-
tionally trafficking may become selectively captured
within stimulated dendritic spines.
Based on the landmark findings of Carson and others,
a compelling model has been put forth of how mRNA
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pathway (Wilhelm and Vale, 1993). It predicts (1) the for-
mation of transport RNPs as a functional complex, (2)
their motor-dependent translocation to their destina-
tions, (3) their anchoring to the local cytoskeleton, and
(4) the translational derepression of the localized
mRNAs. Since the formulation of this model, the chal-
lenge for the last 15 years has been to identify the key
players involved in these processes and to understand
these two processes at the molecular level.
Key Components of Neuronal Transport RNPs
First attempts have been made to purify neuronal RNA
granules in order to utilize proteomics to characterize
the molecular composition of neuronal RNA granules
in a more systematic manner and to begin validating
their functional significance in RNA transport. First,
Krichevsky and Kosik (2001) identified an unusually
heavy sucrose gradient fraction beyond polysomes
that contained ribosomes and Staufen1 and are be-
lieved to represent a fraction enriched for components
of RNA granules. Kanai et al. (2004) isolated large CaM-
KIIa andArcRNA-containing granules from adult mouse
brain that associate with KIF5. Using the RNA interfer-
ence (RNAi) approach, they showed that four of the pro-
teins identified were important for the localization of
aCaMKIIa reporter: Pura, hnRNP U, polypyrimidine tract
binding protein-associated splicing factor (PSF), and
Staufen1. SYNCRIP (hnRNP-Q1) was another mRNA
binding protein identified, although its knockdown in
neurons had no effect on CaMKIIa mRNA localization.
Also identified in this study was the fragile X mental re-
tardation protein (FMRP), an mRNA binding protein
that traffics in RNA granules in dendrites (Antar et al.,
2004). Taken together, the study by Kanai et al. was
groundbreaking in three ways. First, it showed that con-
ventional kinesin is involved in the transport of RNA
granules to dendrites, although it is still unclear which
RNP component binds directly to which kinesin sub-
unit(s). Second, it identified with Pura, hnRNP U, and
PSF three additional essential trans-acting factors for
dendritic RNA transport. Third, it strongly suggested
that granules are composed of many mRNA binding pro-
teins and a number of these may not be essential for
mRNA transport, but instead regulate aspects of RNP
assembly, translation, or stability.
Elvira et al. (2006) biochemically isolated RNA gran-
ules in developing rat brain that were enriched for b-ac-
tin but not forCaMKIIamRNA and contained ribosomes,
a large set of RNA binding proteins, MT-associated pro-
teins, and several novel proteins. One protein identified
was ZBP1, which was known to be required for localiza-
tion of b-actinmRNA granules (Zhang et al., 2001). In ad-
dition, Staufen and hnRNP-A2 were identified as also
being required factors for mRNA localization. Interest-
ingly, both proteomic studies identified a number of
RNA binding proteins, such as Staufen and SYNCRIP,
which was shown by Bannai and colleagues to colocal-
ize with GFP-tagged Staufen1 and inositol 1,4,5-tri-
sphosphate receptor type 1 mRNA in dendritic granules
(Elvira et al., 2006, and reference therein). Another note-
worthy protein family detected in both studies is the
family of DEAD box helicases, which has previously
been implicated in RNP assembly. Elvira et al. (2006) ob-
served that DEAD Box 3 colocalized with RNA granulemarkers and also exhibited BDNF-regulated move-
ments in live hippocampal neurons.
There were also some interesting distinctions be-
tween these two studies. Elvira et al. (2006) identified
ZBP1 in their proteomic analysis of developing brain,
whereas Kanai et al. (2004) did not. The authors hypothe-
sized that there may be different types of RNA granules
that are developmentally regulated and respond to
distinct physiological signals. Together, these studies
open the door toward a more complete understanding
of the composition of neuronal RNA granules and allow
us to address some exciting new questions. One short-
coming of these studies, however, is that very few com-
ponents that came out of these proteomics experiments
have been validated in RNA localization assays, and it is
unclear up to now whether the majority of the identified
components are indeed part of transport RNPs.
What is the experimental evidence for an involvement
of trans-acting factors in RNA localization? The most-
studied example is ZBP1 and its role in the localization
of b-actin mRNA into neurites and growth cones (Zhang
et al., 2001). Antisense oligonucleotides directed against
the 54 nt b-actin zipcode, which disrupt ZBP1 binding to
the zipcode in vitro, blocked the NT-3-induced localiza-
tion of b-actin mRNA into neurites and growth cones
(Zhang et al., 2001). Furthermore, morpholino antisense
oligonucleotides to knock-down ZBP1 resulted in re-
duced dendritic b-actin mRNA localization in cultured
hippocampal neurons, whereas the localization of CaM-
KIIa mRNA was unaffected (Eom et al., 2003). Another
trans-acting factor that has been implicated in dendritic
RNA transport has been mammalian Staufen2. Overex-
pression of dominant-negative Staufen2 significantly
reduced the level of ethidium bromide-stained RNA in
dendrites of polarized neurons (Tang et al., 2001). Unfor-
tunately, there is still nota single mRNAidentified in mam-
malian cells that is recognized by Staufen proteins and
that has been shown to be transported within Staufen-
containing RNA granules. This is in sharp contrast toDro-
sophilaStaufen, which is involved in the localization ofbi-
coid, oskar, and prosperoRNAs in theDrosophila oocyte
and embryo (St Johnston, 2005). Finally, a recent study
reported an essential role of the cytoplasmic polyadeny-
lation element binding protein 1 (CPEB1) in dendritic RNA
transport. Huang et al. (2003) showed that functional but
not mutated CPEs within the 170 nt 30-UTR of wild-type
CaMKIIa mRNA are sufficient to target a reporter RNA
into dendrites of hippocampal neurons. To demonstrate
a requirement for CPEB1 in dendritic mRNA localization,
cultured neurons from CPEB1 knockout mice showed re-
duced localization of EGFP reporters harboring CPE se-
quences in the 30-UTR. The study by Huang et al. (2003)
showed that endogenous mRNAs that contain a CPE,
e.g.,CaMKIIaandMAP2mRNAs, were reduced in synap-
tosome preparations isolated from cultured neurons that
were infected with a dominant-negative CPEB construct.
Reduced mRNA levels of MAP2 mRNA were also con-
firmed by FISH, further suggesting a role for CPEB in
mRNA localization. As other studies have identified
a role for different localization elements within the CaM-
KIIamRNA 30-UTR other than the CPE (Rook et al., 2000),
it is likely that there may be additional localization ele-
ments, and further work is needed to assess whether
the CPE is necessary for mRNA localization.
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how transport RNPs are assembled. An RNP complex
containing the survival of motor neuron protein (SMN)
and gemin proteins facilitates the assembly of spliceoso-
mal RNPs, which may play a comparable role in assem-
bly of transport RNPs in neurons (Monani, 2005). Rossoll
and coworkers have shown that SMN binds SYNCRIP
(Monani, 2005, and reference therein), which was identi-
fied in the above proteomics screens of RNA granules
(Kanai et al., 2004; Elvira et al., 2006). SMN-GFP granules
are actively transported in association with gemin pro-
teins in live neurons (Zhang et al., 2006, and references
therein). The inherited loss of SMN is the cause of the
neurodegenerative disease spinal muscular atrophy
(SMA). Mouse neurons cultured from a transgenic mouse
model of SMA have impaired localization of b-actin
mRNA in axonal growth cones, suggesting possible in-
teractions of SMN complexes with mRNA binding pro-
teins, e.g., ZBP1 and SYNCRIP involved in mRNA locali-
zation (Monani, 2005, and references therein). Future
work is needed to understand whether impaired mRNP
assembly and localization contribute to SMA.
Coupling mRNA Transport with Translation
for Neuronal Function
Most approaches described so far tried to understand
the molecular mechanisms of how individual mRNAs
are transported in the form of granules using cultured
neurons as a model. The identification of various com-
ponents of the translational machinery in dendrites
and near synapses (Klann and Dever, 2004, and refer-
ences therein) revealed several important questions. Is
RNA transport coupled with translation, and how is
this achieved? Are mRNAs generally repressed within
the observed transport RNPs? What causes the activa-
tion of translation? In addition, more than one class of
transport RNP might exist. In the case of mammalian
staufen proteins, there is biochemical evidence that
some RNA granules contain ribosomes, whereas others
do not. When fractionated by size, the largest Staufen
pools contained ribosomal and ER markers, whereas
the smaller RNA granules were free of ribosomes and
ER but cofractionated with conventional kinesin (Mal-
lardo et al., 2003). This suggested that the smaller RNA
granules might represent the observed transport RNPs
(Ko¨hrmann et al., 1999). Krichevsky and Kosik provided
first evidence that mRNAs might be indeed translation-
ally repressed within granules, since they can be re-
leased and/or derepressed in response to neuronal ac-
tivity, allowing for local translation (Krichevsky and
Kosik, 2001; see also Hu¨ttelmaier et al., 2005).
Since this first observation, efforts were made to iden-
tify mRNA binding proteins in transport RNPs that might
regulate mRNA translation. RNG105 was shown by
Shiina and colleagues to be a component of dendritic
RNA granules that can repress mRNA translation in vitro
and in vivo (Elvira et al., 2006, and reference therein). In
response to BDNF, the release of RNG105 from RNA
granules was correlated with activation of mRNA re-
porter translation. Huang an coworkers showed that
translational repression of mRNAs containing CPEs by
CPEB could be derepressed by NMDA receptor stimula-
tion, allowing for synaptic protein synthesis (Huang
et al., 2003, and reference therein). This CPEB-depen-
dent mechanism involves regulation of a multiproteinRNP complex that represses translation initiation. In
response to NMDA receptor activation, CPEB is phos-
phorylated by aurora kinase, leading to the dissociation
of maskin from eIF4E. CPSF is recruited, polyadenyla-
tion ensues, and translation is activated.
In the case of ZBP1, phosphorylation by Src led to the
release of ZBP1 from b-actin mRNA, allowing for spatial
regulation of local b-actin synthesis beneath the mem-
brane (Hu¨ttelmaier et al., 2005). Evidence also indicates
that ZBP1 can repress the joining of ribosomal subunits,
indicating regulation at the level of translation initiation.
Taken together, these studies suggest that mRNA trans-
port and translation may be inextricably linked pro-
cesses through regulation of mRNA binding proteins,
such as CPEB and ZBP1, constituents of transport
RNPs. Future work is clearly needed to identify whether
any of these mRNA binding proteins can function as an
adaptor between the mRNA cis-acting element and the
motor subunit, thus serving a dual role in the coupling
of mRNA transport to translational control.
Fragile X syndrome is the most common inherited form
of mental retardation caused by the loss of FMRP, an
mRNA binding protein that is known to regulate transla-
tion and traffic in dendrites (Zalfa et al., 2006). FMRP
granules containing mRNAs traffic into dendrites upon
activation of metabotropic glutamate receptors (Antar
et al., 2004), although it is still unclear whether FMRP is
an essential factor for mRNA localization. Several stud-
ies indicate that FMRP plays a critical role in regulation
of mRNA translation, perhaps serving as a link between
transport RNPs and polyribosomes. Biochemical analy-
sis indicates that FMRP is broadly distributed on sucrose
gradients, and it is detected in both RNPs and polyribo-
somes (Zalfa et al., 2006). FMRP can repress mRNA
translation in vitro and in vivo (Zalfa et al., 2006). One
model is that FMRP, when present in polyribosomes,
may repress ribosome elongation. Consistent with a
stalled ribosome model, FMRP associated with polyribo-
somes is heavily phosphorylated, whereas dephosphory-
lation allows ribosomes to translate mRNA and run-off
(Zalfa et al., 2006, and reference therein). FMRP within
mRNPs may regulate translation by another mechanism.
Some evidence indicates that FMRP can bind BC1,
a small noncoding RNA, which may act as a bridge to de-
liver FMRP to complementary mRNAs (Zalfa et al., 2006).
The Tiedge laboratory has characterized distinct cis-act-
ing elements within the BC1 RNA that are needed for
dendritic mRNA transport and repression of translation
initiation by binding PABP and eIF4A, thus inhibiting
translation initiation (Wang et al., 2005). FMRP and BC1
RNA binding was not detected by this group. A third
mode of FMRP translation regulation potentially involves
interactions of FMRP with microRNAs (miRNAs) and the
RNA-induced silencing complex (RISC) (Zalfa et al., 2006).
Further work should reveal which miRNAs associate with
FMRP to regulate mRNA translation. In summary, FMRP
has multiple modes of interactions to regulate translation
in RNPs and polyribosomes. It will be interesting to ex-
amine specific defects in activity-dependent trafficking
of transport RNPs and their translation in neurons from
a mouse model of fragile X syndrome, which has
emerged as a powerful model for analysis of the function
of localized RNPs in specific forms of protein synthesis-
dependent synaptic plasticity (Zalfa et al., 2006).
Minireview
689As mediators of mRNA transport and translation,
some mRNA binding proteins affect neuronal morph-
ology and function, and their deficiency may underlie
genetic neurological diseases. A dendritic spine pheno-
type in human fragile X syndrome and the correspond-
ing mouse model is characterized by an excess of long
and thin filopodial-like spines and a reduction in mature
spines, which may be due to dysregulated protein syn-
thesis at synapses (Zalfa et al., 2006). Another prominent
example is the mRNA binding protein TLS (translocated
in liposarcoma) that has been previously identified as
a component of neuronal RNA granules and shown to
translocate into spines of hippocampal neurons in re-
sponse to mGluR5 activation. Neurons cultured from
TLS null mice showed an excess of filopodial-like or
thin spines lacking heads and a reduction of mature
spines having a mushroom shape (Fujii et al., 2005). A
third RNA binding protein is mammalian Staufen2. Hip-
pocampal neurons deficient for Staufen2 have reduced
dendritic spines and increased filopodia, which result,
in part, from impaired b-actinmRNA localization (Goetze
et al., 2006). Collectively, these studies demonstrate the
role of mRNA regulation by mRNA binding proteins in
translation affecting spine development, which likely
have important consequences for synaptic plasticity,
learning, and memory (Klann and Dever, 2004).
Diversity of Neuronal RNA Granules
There is good evidence that transport of mRNAs and
translational regulation might be intimately coupled. In
neurons, it is generally believed that the transported
mRNAs are translationally repressed during transport.
New and exciting evidence is now emerging that indi-
cates that translation is activated by specific synaptic in-
puts (Hu¨ttelmaier et al., 2005; Ashraf et al., 2006; Schratt
et al., 2006). The underlying molecular mechanisms of
this translational silencing, however, are mainly un-
known. There are several interesting scenarios for how
this might be achieved in neurons. First, a fair number
of translational repressor molecules have been identified
that might be responsible for this translational regulation
(Klann and Dever, 2004). With the identification of stress
granules (SGs) (Table 1), another type of RNA granule
(Anderson and Kedersha, 2006), another scenario might
be envisioned in dendrites of mature neurons. SGs have
been recently proposed to recruit specific mRNA tran-
scripts, thereby regulating their stability and translation
(Anderson and Kedersha, 2006). Staufen proteins, estab-
lished markers for RNA transport in neurons, as well as
the mammalian Pumilio2 protein, can be transferred
from neuronal RNA granules into dendritic SGs in re-
sponse to stress (Vessey et al., 2006, and references
therein). This is also true for FMRP, as shown by Kim
and colleagues, to move out of polyribosomes and into
SGs upon oxidative stress (Zalfa et al., 2006, and refer-
ence therein). To our knowledge, the vast majority of
RNA binding proteins, such as Pumilio2, Barentsz,
FMRP, Staufen proteins, and PABP, are sequestered
into SGs upon stress. Future work will therefore have to
unravel whether the sequestration of mRNAs to SGs
may have a function in translational regulation in neurons
under physiological conditions. Furthermore, one would
like to understand whether transport RNPs might be
remodeled into SGs upon stress induction or whether
they are distinct structures with separate functions. Itwill also be interesting to see whether SGs are relatively
fixed in their subcellular localization as suggested by
Anderson and Kedersha (2006), or alternatively, whether
SGs are more mobile than previously anticipated.
Another interesting avenue is the role of processing
bodies (P bodies) (Table 1), yet another type of RNA
granule (Anderson and Kedersha, 2006) in dendrites of
polarized neurons. P bodies contain components of
the 50-30 mRNA decay machinery, the nonsense-medi-
ated decay pathway, and, most notably, factors in-
volved in small RNA-guided gene silencing. miRNA-
guided translational silencing as well as siRNA-guided
RNA degradation occur in P bodies. Recent work
showed that the sequestration of mRNAs to P bodies
may prevent their translation (Brengues et al., 2005).
Upon specific signals, such repressed mRNAs can
even be released into the cytoplasm for further transla-
tion. This is of particular relevance in that miR-134 was
recently found in dendritic RNA granules together with
its target mRNA, encoding Lim protein kinase 1
(Limk1) (Schratt et al., 2006). miR-134 appears to inhibit
the translation of Limk1 at the synapse and causes a
reduction in the size of dendritic spines. Interestingly,
exposure of neurons to BDNF relieves the inhibition of
Limk1 translation. It is currently unknown whether the
observed Limk1 mRNA and miR-134-positive granules
represent transport RNPs or rather another type of neu-
ronal RNA granule, such as P bodies. Therefore, several
possible mechanisms can be envisioned. First, the den-
dritically localized Limk1 mRNA assembles together
with miR-134 into transport RNPs, thereby translation-
ally silencing the mRNA during transport. This may re-
quire that components of the RISC complex, such as
dicer or argonaute proteins, be present in these trans-
port RNPs as well. Alternatively, Limk mRNA could be
transported via transport RNPs into dendrites where,
subsequently, additional components of the RISC com-
plex are acquired, converting the transport RNPs into P
bodies. Recent work has shown that key components of
P bodies, such as Dcp1a and Lsm1, exist in dendrites of
mature hippocampal neurons (Vessey et al., 2006). It will
be exciting to find out whether SGs and P bodies are
structures that show motility and whether these RNA
granules form in the cell body and are then transported
into dendrites, or, alternatively, whether they form in
dendrites near synapses. Although the functional signifi-
cance of P bodies in dendrites and near synapses is still
unknown, there is evidence suggesting that P bodies
might be involved in regulated, local degradation of cer-
tain mRNAs in dendrites such asGluR1/2mRNA (Grooms
et al., 2006). Further work will therefore have to define
the various functions of P bodies at the synapse.
What could be the function(s) of the RISC complex
at synapses? At least one RISC factor, the helicase Ar-
mitage (Cook et al., 2004), is localized to synapses and
degraded by the proteasome in response to neural ac-
tivity (Ashraf et al., 2006). These investigators proposed
the exciting new model that during the formation of
long-term memory, Armitage becomes degraded by
the proteasome, thereby allowing synaptic protein syn-
thesis and mRNA transport from miRNA-dependent
suppression.
In conclusion, recent work has convincingly demon-
strated that neuronal RNA granules are much more
Neuron
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also in function than previously anticipated. Neuronal
RNA granules may represent multifunctional molecular
machines that are complex, dynamic structures exerting
different intracellular functions. Transport RNPs achieve
RNA localization and thus warrant precise translational
control during transport. An important direction for fu-
ture work will be to further identify which mRNA binding
proteins are essential for mRNA transport, some of them
possibly serving as a direct adaptor with subunits of mo-
lecular motors. We also need to identify whether there
are different types of transport RNPs, harboring differ-
ent mRNAs and associated binding proteins, which
may be developmentally regulated and respond to dis-
tinct physiological signals. The presence of SGs in
dendrites near synapses suggests that mRNAs may be
temporarily stalled for translation upon cellular stress.
Whether SGs play a role in translational silencing under
physiological conditions remains to be shown. Finally,
the discovery of P bodies and microRNAs in dendrites
and near synapses immediately suggests a novel and
exciting new mechanism for translational silencing and
even mRNA degradation. Taken together, future work
will have to unravel the precise contributions of these
types of neuronal granules to RNA localization, micro-
RNA-mediated translational silencing, and mRNA deg-
radation at the synapse. An important challenge will
also be to extrapolate which features of RNA granules
and their regulation, observed so far in cultured neurons,
will play important roles in vivo. Since neuronal activity
and synaptic signaling are known to affect mRNA trans-
port and translation in vivo, the likelihood that the RNA
granules here play critical and diverse roles is very
strong. Based on the presented findings, we speculate
that all of these mechanisms surrounding RNA granules
allow for synapse-specific modifications, thereby yield-
ing molecular, structural, and functional reorganization
of individual synapses that occur during neuronal de-
velopment and synaptic plasticity, processes which
may go awry in neurological diseases such as fragile
X syndrome.
Acknowledgments
The authors apologize for omitted references. We gratefully ac-
knowledge the support from the FWF, the HFSP, the Schram Foun-
dation, and from the MUW through Wolfgang Schu¨tz (to M.A.K.), as
well as NINDS, NICHD, and the Dana Foundation (to G.J.B.). The au-
thors would like to thank the following colleagues: Ralf Dahm, Ralf-
Peter Jansen, Paolo Macchi, Gunter Meister, Mani Ramaswami,
Daniel St. Johnston, and John Vessey.
Selected Reading
Ainger, K., Avossa, D., Morgan, F., Hill, S.J., Barry, C., Barbarese, E.,
and Carson, J.H. (1993). J. Cell Biol. 123, 431–441.
Anderson, P., and Kedersha, N. (2006). J. Cell Biol. 172, 803–808.
Antar, L.N., Afroz, R., Dictenberg, J.B., Carroll, R.C., and Bassell,
G.J. (2004). J. Neurosci. 24, 2648–2655.
Ashraf, S.I., McLoon, A.L., Sclarsic, S.M., and Kunes, S. (2006). Cell
124, 191–205.
Brengues, M., Teixeira, D., and Parker, R. (2005). Science 310, 486–
489.
Cook, H.A., Koppetsch, B.S., Wu, J., and Theurkauf, W.E. (2004). Cell
116, 817–829.Elvira, G., Wasiak, S., Blandford, V., Tong, X.K., Serrano, A., Fan, X.,
del Rayo Sanchez-Carbente, M., Servant, F., Bell, A.W., Boismenu,
D., et al. (2006). Mol. Cell. Proteomics 5, 635–651.
Eom, T., Antar, L.N., Singer, R.H., and Bassell, G.J. (2003). J. Neuro-
sci. 23, 10433–10444.
Fujii, R., Okabe, S., Urushido, T., Inoue, K., Yoshimura, A., Tachi-
bana, T., Nishikawa, T., Hicks, G.G., and Takumi, T. (2005). Curr.
Biol. 15, 587–593.
Goetze, B., Tuebing, F., Xie, Y., Dorostkar, M.M., Thomas, S., Pehl,
U., Boehm, S., Macchi, P., and Kiebler, M.A. (2006). J. Cell Biol.
172, 221–231.
Grooms, S.Y., Noh, K.M., Regis, R., Bryan, M.K., Bassell, G.J., Car-
roll, R.C., and Zukin, R.S. (2006). J. Neurosci. 26, 8339–8351.
Huang, Y.S., Carson, J.H., Barbarese, E., and Richter, J.D. (2003).
Genes Dev. 17, 638–653.
Hu¨ttelmaier, S., Zenklusen, D., Lederer, M., Dictenberg, J., Lorenz,
M., Meng, X., Bassell, G.J., Condeelis, J., and Singer, R.H. (2005).
Nature 438, 512–515.
Kanai, Y., Dohmae, N., and Hirokawa, N. (2004). Neuron 43, 513–525.
Kiebler, M.A., and DesGroseillers, L. (2000). Neuron 25, 19–28.
Klann, E., and Dever, T.E. (2004). Nat. Rev. Neurosci. 5, 931–942.
Knowles, R.B., Sabry, J.H., Martone, M.E., Deerinck, T.F., Ellisman,
M.H., Bassell, G.J., and Kosik, K.S. (1996). J. Neurosci. 16, 7812–
7820.
Ko¨hrmann, M., Luo, M., Kaether, C., DesGroseillers, L., Dotti, C.G.,
and Kiebler, M.A. (1999). Mol. Biol. Cell 10, 2945–2953.
Krichevsky, A.M., and Kosik, K.S. (2001). Neuron 32, 683–696.
Mallardo, M., Deitinghoff, A., Mu¨ller, J., Goetze, B., Macchi, P., Pe-
ters, C., and Kiebler, M.A. (2003). Proc. Natl. Acad. Sci. USA 100,
2100–2105.
Monani, U. (2005). Neuron 48, 885–896.
Rook, M.S., Lu, M., and Kosik, K.S. (2000). J. Neurosci. 20, 6385–
6393.
Schmid, M., Jaedicke, A., Gu, T.G., and Jansen, R.P. (2006). Curr.
Biol. 16, 1538–1543.
Schratt, G., Tuebing, F., Nigh, E.A., Kane, C., Sabatini, M.W., Kiebler,
M.A., and Greenberg, M.E. (2006). Nature 439, 283–289.
St Johnston, D. (2005). Nat. Rev. Mol. Cell Biol. 6, 363–375.
Tang, S.J., Meulemans, D., Vazquez, L., Colaco, N., and Schuman, E.
(2001). Neuron 32, 463–475.
Vessey, J.P., Vaccani, A., Xie, Y., Dahm, R., Karra, D., Kiebler, M.A.,
and Macchi, P. (2006). J. Neurosci. 26, 6496–6508.
Wang, H., Iacoangeli, A., Lin, D., Williams, K., Denman, R.B., Hellen,
C.U., and Tiedge, H. (2005). J. Cell Biol. 171, 811–821.
Wilhelm, J.E., and Vale, R.D. (1993). J. Cell Biol. 123, 269–274.
Willis, D., Li, K.W., Zheng, J.Q., Chang, J.H., Smit, A., Kelly, T., Mer-
ianda, T.T., Sylvester, J., van Minnen, J., and Twiss, J.L. (2005). J.
Neurosci. 25, 778–791.
Zalfa, F., Achsel, T., and Bagni, C. (2006). Curr. Opin. Neurobiol. 16,
265–269.
Zhang, H.L., Eom, T., Oleynikov, Y., Shenoy, S.M., Liebelt, D.A., Dic-
tenberg, J.B., Singer, R.H., and Bassell, G.J. (2001). Neuron 31, 261–
275.
Zhang, H.L., Xing, L., Rossoll, W.M., Wichterle, H., Singer, R.H., and
Bassell, G.J. (2006). J. Neurosci. 26, 8622–8632.
